ID   POMT1_HUMAN             Reviewed;         747 AA.
AC   Q9Y6A1; B3KQG0; B4DIF0; Q5JT01; Q5JT06; Q5JT08; Q8NC91; Q8TCA9; Q9NX32;
AC   Q9NX82; Q9UNT2;
DT   20-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 3.
DT   18-JUN-2025, entry version 209.
DE   RecName: Full=Protein O-mannosyl-transferase 1;
DE            EC=2.4.1.109 {ECO:0000269|PubMed:14699049, ECO:0000269|PubMed:28512129};
DE   AltName: Full=Dolichyl-phosphate-mannose--protein mannosyltransferase 1;
GN   Name=POMT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE
RP   SPLICING, AND VARIANT ARG-251.
RC   TISSUE=Fetal brain;
RX   PubMed=10366449; DOI=10.1006/geno.1999.5819;
RA   Perez Jurado L.A., Coloma A., Cruces J.;
RT   "Identification of a human homolog of the Drosophila rotated abdomen gene
RT   (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment
RT   to human chromosome 9q34.1.";
RL   Genomics 58:171-180(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 53-747 (ISOFORM 1), AND VARIANT ARG-251.
RC   TISSUE=Hippocampus, Ileal mucosa, Signet-ring cell carcinoma, and
RC   Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND VARIANTS MDDGA1 ARG-76 AND ASP-428.
RX   PubMed=12369018; DOI=10.1086/342975;
RA   Beltran-Valero de Bernabe D., Currier S., Steinbrecher A., Celli J.,
RA   van Beusekom E., van der Zwaag B., Kayserili H., Merlini L., Chitayat D.,
RA   Dobyns W.B., Cormand B., Lehesjoki A.-E., Cruces J., Voit T., Walsh C.A.,
RA   van Bokhoven H., Brunner H.G.;
RT   "Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe
RT   neuronal migration disorder Walker-Warburg syndrome.";
RL   Am. J. Hum. Genet. 71:1033-1043(2002).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14699049; DOI=10.1073/pnas.0307228101;
RA   Manya H., Chiba A., Yoshida A., Wang X., Chiba Y., Jigami Y.,
RA   Margolis R.U., Endo T.;
RT   "Demonstration of mammalian protein O-mannosyltransferase activity:
RT   coexpression of POMT1 and POMT2 required for enzymatic activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:500-505(2004).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-471.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=28512129; DOI=10.1074/jbc.m117.794487;
RA   Larsen I.S.B., Narimatsu Y., Joshi H.J., Yang Z., Harrison O.J., Brasch J.,
RA   Shapiro L., Honig B., Vakhrushev S.Y., Clausen H., Halim A.;
RT   "Mammalian O-mannosylation of cadherins and plexins is independent of
RT   protein O-mannosyltransferases 1 and 2.";
RL   J. Biol. Chem. 292:11586-11598(2017).
RN   [11]
RP   VARIANT MDDGA1 LEU-421 DEL.
RX   PubMed=15037715; DOI=10.1212/01.wnl.0000115386.28769.65;
RA   Kim D.-S., Hayashi Y.K., Matsumoto H., Ogawa M., Noguchi S., Murakami N.,
RA   Sakuta R., Mochizuki M., Michele D.E., Campbell K.P., Nonaka I.,
RA   Nishino I.;
RT   "POMT1 mutation results in defective glycosylation and loss of laminin-
RT   binding activity in alpha-DG.";
RL   Neurology 62:1009-1011(2004).
RN   [12]
RP   VARIANT MDDGA1 ARG-537.
RX   PubMed=15637732; DOI=10.1002/ajmg.a.30487;
RA   Currier S.C., Lee C.K., Chang B.S., Bodell A.L., Pai G.S., Job L.,
RA   Lagae L.G., Al-Gazali L.I., Eyaid W.M., Enns G., Dobyns W.B., Walsh C.A.;
RT   "Mutations in POMT1 are found in a minority of patients with Walker-Warburg
RT   syndrome.";
RL   Am. J. Med. Genet. A 133:53-57(2005).
RN   [13]
RP   VARIANT MDDGC1 PRO-200.
RX   PubMed=15792865; DOI=10.1016/j.nmd.2005.01.013;
RA   Balci B., Uyanik G., Dincer P., Gross C., Willer T., Talim B.,
RA   Haliloglu G., Kale G., Hehr U., Winkler J., Topaloglu H.;
RT   "An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild
RT   mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a
RT   mutation in the POMT1 gene.";
RL   Neuromuscul. Disord. 15:271-275(2005).
RN   [14]
RP   VARIANTS MDDGB1 ARG-65; MET-140 DEL; CYS-582 AND HIS-590, VARIANTS MDDGA1
RP   CYS-105; HIS-105 AND VAL-207, AND VARIANTS PHE-285 AND LYS-522.
RX   PubMed=16575835; DOI=10.1002/humu.20313;
RA   van Reeuwijk J., Maugenre S., van den Elzen C., Verrips A., Bertini E.,
RA   Muntoni F., Merlini L., Scheffer H., Brunner H.G., Guicheney P.,
RA   van Bokhoven H.;
RT   "The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome
RT   to congenital muscular dystrophy, microcephaly, and mental retardation.";
RL   Hum. Mutat. 27:453-459(2006).
RN   [15]
RP   VARIANTS MDDGB1 ARG-65; HIS-590 AND THR-669.
RX   PubMed=16717220; DOI=10.1212/01.wnl.0000216145.66476.36;
RA   D'Amico A., Tessa A., Bruno C., Petrini S., Biancheri R., Pane M.,
RA   Pedemonte M., Ricci E., Falace A., Rossi A., Mercuri E., Santorelli F.M.,
RA   Bertini E.;
RT   "Expanding the clinical spectrum of POMT1 phenotype.";
RL   Neurology 66:1564-1567(2006).
RN   [16]
RP   VARIANTS MDDGB1 ARG-65 AND ARG-537.
RX   PubMed=19299310; DOI=10.1212/01.wnl.0000346518.68110.60;
RA   Mercuri E., Messina S., Bruno C., Mora M., Pegoraro E., Comi G.P.,
RA   D'Amico A., Aiello C., Biancheri R., Berardinelli A., Boffi P.,
RA   Cassandrini D., Laverda A., Moggio M., Morandi L., Moroni I., Pane M.,
RA   Pezzani R., Pichiecchio A., Pini A., Minetti C., Mongini T., Mottarelli E.,
RA   Ricci E., Ruggieri A., Saredi S., Scuderi C., Tessa A., Toscano A.,
RA   Tortorella G., Trevisan C.P., Uggetti C., Vasco G., Santorelli F.M.,
RA   Bertini E.;
RT   "Congenital muscular dystrophies with defective glycosylation of
RT   dystroglycan: a population study.";
RL   Neurology 72:1802-1809(2009).
CC   -!- FUNCTION: Transfers mannosyl residues to the hydroxyl group of serine
CC       or threonine residues. Coexpression of both POMT1 and POMT2 is
CC       necessary for enzyme activity, expression of either POMT1 or POMT2
CC       alone is insufficient (PubMed:12369018, PubMed:14699049,
CC       PubMed:28512129). Essentially dedicated to O-mannosylation of alpha-
CC       DAG1 and few other proteins but not of cadherins and protocaherins
CC       (PubMed:28512129). {ECO:0000269|PubMed:12369018,
CC       ECO:0000269|PubMed:14699049, ECO:0000269|PubMed:28512129}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a di-trans,poly-cis-dolichyl beta-D-mannosyl phosphate + L-
CC         seryl-[protein] = 3-O-(alpha-D-mannosyl)-L-seryl-[protein] + a di-
CC         trans,poly-cis-dolichyl phosphate + H(+); Xref=Rhea:RHEA:17377,
CC         Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:13546, Rhea:RHEA-COMP:19498,
CC         Rhea:RHEA-COMP:19501, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,
CC         ChEBI:CHEBI:57683, ChEBI:CHEBI:58211, ChEBI:CHEBI:137321;
CC         EC=2.4.1.109; Evidence={ECO:0000269|PubMed:14699049,
CC         ECO:0000269|PubMed:28512129};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a di-trans,poly-cis-dolichyl beta-D-mannosyl phosphate + L-
CC         threonyl-[protein] = 3-O-(alpha-D-mannosyl)-L-threonyl-[protein] + a
CC         di-trans,poly-cis-dolichyl phosphate + H(+); Xref=Rhea:RHEA:53396,
CC         Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:13547, Rhea:RHEA-COMP:19498,
CC         Rhea:RHEA-COMP:19501, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:57683, ChEBI:CHEBI:58211, ChEBI:CHEBI:137323;
CC         EC=2.4.1.109; Evidence={ECO:0000269|PubMed:14699049,
CC         ECO:0000269|PubMed:28512129};
CC   -!- ACTIVITY REGULATION: Slightly activated by Mg(2+) and inhibited by both
CC       Ca(+) and Mn(2+). EDTA ha no effect on activity in vitro.
CC       {ECO:0000269|PubMed:14699049}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Interacts with POMT2. {ECO:0000305}.
CC   -!- INTERACTION:
CC       Q9Y6A1-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12337033, EBI-16439278;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:14699049}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:14699049}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9Y6A1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6A1-2; Sequence=VSP_007591;
CC       Name=3;
CC         IsoId=Q9Y6A1-3; Sequence=VSP_007590, VSP_007591;
CC       Name=4;
CC         IsoId=Q9Y6A1-4; Sequence=VSP_041024, VSP_007591;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in testis, heart
CC       and pancreas. Detected at lower levels in kidney, skeletal muscle,
CC       brain, placenta, lung and liver.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with impaired
CC       intellectual development B1 (MDDGB1) [MIM:613155]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with intellectual disability and mild structural brain
CC       abnormalities. {ECO:0000269|PubMed:16575835,
CC       ECO:0000269|PubMed:16717220, ECO:0000269|PubMed:19299310}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with brain
CC       and eye anomalies A1 (MDDGA1) [MIM:236670]: An autosomal recessive
CC       disorder characterized by congenital muscular dystrophy associated with
CC       cobblestone lissencephaly and other brain anomalies, eye malformations,
CC       profound intellectual disability, and death usually in the first years
CC       of life. Included diseases are the more severe Walker-Warburg syndrome
CC       and the slightly less severe muscle-eye-brain disease.
CC       {ECO:0000269|PubMed:12369018, ECO:0000269|PubMed:15037715,
CC       ECO:0000269|PubMed:15637732, ECO:0000269|PubMed:16575835}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C1 (MDDGC1)
CC       [MIM:609308]: An autosomal recessive degenerative myopathy associated
CC       with mild intellectual disability without any obvious structural brain
CC       abnormality. An abnormal alpha-dystroglycan pattern in observed in the
CC       muscle. {ECO:0000269|PubMed:15792865}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 39 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91135.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA91190.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF095136; AAD41245.1; -; mRNA.
DR   EMBL; AF095150; AAD41246.1; -; Genomic_DNA.
DR   EMBL; AF095138; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095139; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095140; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095141; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095142; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095143; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095144; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095145; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095146; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095147; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095148; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095149; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AK000391; BAA91135.1; ALT_INIT; mRNA.
DR   EMBL; AK000475; BAA91190.1; ALT_INIT; mRNA.
DR   EMBL; AK295561; BAG58462.1; -; mRNA.
DR   EMBL; AK074874; BAG52022.1; -; mRNA.
DR   EMBL; AK074888; BAC11269.1; -; mRNA.
DR   EMBL; AL358781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW87978.1; -; Genomic_DNA.
DR   EMBL; BC022877; AAH22877.3; -; mRNA.
DR   EMBL; BC065268; AAH65268.1; -; mRNA.
DR   CCDS; CCDS43894.1; -. [Q9Y6A1-2]
DR   CCDS; CCDS43895.1; -. [Q9Y6A1-3]
DR   CCDS; CCDS48045.1; -. [Q9Y6A1-4]
DR   CCDS; CCDS6943.1; -. [Q9Y6A1-1]
DR   RefSeq; NP_001070833.1; NM_001077365.2. [Q9Y6A1-2]
DR   RefSeq; NP_001070834.1; NM_001077366.2. [Q9Y6A1-3]
DR   RefSeq; NP_001129585.1; NM_001136113.2. [Q9Y6A1-2]
DR   RefSeq; NP_001129586.1; NM_001136114.2. [Q9Y6A1-4]
DR   RefSeq; NP_001340122.2; NM_001353193.2. [Q9Y6A1-1]
DR   RefSeq; NP_001340123.1; NM_001353194.2. [Q9Y6A1-3]
DR   RefSeq; NP_001340124.1; NM_001353195.2. [Q9Y6A1-4]
DR   RefSeq; NP_001361620.1; NM_001374691.1. [Q9Y6A1-4]
DR   RefSeq; NP_001361621.1; NM_001374692.1. [Q9Y6A1-4]
DR   RefSeq; NP_009102.3; NM_007171.3. [Q9Y6A1-1]
DR   RefSeq; XP_005272213.1; XM_005272156.1.
DR   AlphaFoldDB; Q9Y6A1; -.
DR   SMR; Q9Y6A1; -.
DR   BioGRID; 115834; 62.
DR   ComplexPortal; CPX-2659; POMT1-POMT2 O-mannosyltransferase complex.
DR   FunCoup; Q9Y6A1; 860.
DR   IntAct; Q9Y6A1; 44.
DR   STRING; 9606.ENSP00000361302; -.
DR   CAZy; GT39; Glycosyltransferase Family 39.
DR   GlyCosmos; Q9Y6A1; 3 sites, No reported glycans.
DR   GlyGen; Q9Y6A1; 5 sites, 7 N-linked glycans (4 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Y6A1; -.
DR   PhosphoSitePlus; Q9Y6A1; -.
DR   SwissPalm; Q9Y6A1; -.
DR   BioMuta; POMT1; -.
DR   DMDM; 332278226; -.
DR   jPOST; Q9Y6A1; -.
DR   MassIVE; Q9Y6A1; -.
DR   PaxDb; 9606-ENSP00000361302; -.
DR   PeptideAtlas; Q9Y6A1; -.
DR   ProteomicsDB; 86636; -. [Q9Y6A1-1]
DR   ProteomicsDB; 86637; -. [Q9Y6A1-2]
DR   ProteomicsDB; 86638; -. [Q9Y6A1-3]
DR   ProteomicsDB; 86639; -. [Q9Y6A1-4]
DR   Pumba; Q9Y6A1; -.
DR   Antibodypedia; 31602; 192 antibodies from 27 providers.
DR   DNASU; 10585; -.
DR   Ensembl; ENST00000341012.13; ENSP00000343034.7; ENSG00000130714.19. [Q9Y6A1-3]
DR   Ensembl; ENST00000372228.9; ENSP00000361302.3; ENSG00000130714.19. [Q9Y6A1-1]
DR   Ensembl; ENST00000402686.8; ENSP00000385797.4; ENSG00000130714.19. [Q9Y6A1-2]
DR   Ensembl; ENST00000676640.1; ENSP00000503281.1; ENSG00000130714.19. [Q9Y6A1-2]
DR   Ensembl; ENST00000677216.1; ENSP00000503772.1; ENSG00000130714.19. [Q9Y6A1-4]
DR   Ensembl; ENST00000679023.1; ENSP00000503718.1; ENSG00000130714.19. [Q9Y6A1-3]
DR   Ensembl; ENST00000679189.1; ENSP00000503356.1; ENSG00000130714.19. [Q9Y6A1-4]
DR   GeneID; 10585; -.
DR   KEGG; hsa:10585; -.
DR   MANE-Select; ENST00000402686.8; ENSP00000385797.4; NM_001077365.2; NP_001070833.1. [Q9Y6A1-2]
DR   UCSC; uc004cau.4; human. [Q9Y6A1-1]
DR   AGR; HGNC:9202; -.
DR   CTD; 10585; -.
DR   DisGeNET; 10585; -.
DR   GeneCards; POMT1; -.
DR   HGNC; HGNC:9202; POMT1.
DR   HPA; ENSG00000130714; Low tissue specificity.
DR   MalaCards; POMT1; -.
DR   MIM; 236670; phenotype.
DR   MIM; 607423; gene.
DR   MIM; 609308; phenotype.
DR   MIM; 613155; phenotype.
DR   neXtProt; NX_Q9Y6A1; -.
DR   OpenTargets; ENSG00000130714; -.
DR   Orphanet; 370959; Congenital muscular dystrophy with cerebellar involvement.
DR   Orphanet; 370968; Congenital muscular dystrophy with intellectual disability.
DR   Orphanet; 370980; Congenital muscular dystrophy without intellectual disability.
DR   Orphanet; 588; Muscle-eye-brain disease.
DR   Orphanet; 86812; POMT1-related limb-girdle muscular dystrophy R11.
DR   Orphanet; 899; Walker-Warburg syndrome.
DR   PharmGKB; PA33527; -.
DR   VEuPathDB; HostDB:ENSG00000130714; -.
DR   eggNOG; KOG3359; Eukaryota.
DR   GeneTree; ENSGT00940000158049; -.
DR   HOGENOM; CLU_008438_1_0_1; -.
DR   InParanoid; Q9Y6A1; -.
DR   OMA; NCHLNAP; -.
DR   OrthoDB; 292747at2759; -.
DR   PAN-GO; Q9Y6A1; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9Y6A1; -.
DR   TreeFam; TF300552; -.
DR   BioCyc; MetaCyc:HS05428-MONOMER; -.
DR   BRENDA; 2.4.1.109; 2681.
DR   PathwayCommons; Q9Y6A1; -.
DR   Reactome; R-HSA-5083629; Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2.
DR   Reactome; R-HSA-5083633; Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1.
DR   Reactome; R-HSA-5173105; O-linked glycosylation.
DR   SignaLink; Q9Y6A1; -.
DR   SIGNOR; Q9Y6A1; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 10585; 16 hits in 1156 CRISPR screens.
DR   ChiTaRS; POMT1; human.
DR   GeneWiki; POMT1; -.
DR   GenomeRNAi; 10585; -.
DR   Pharos; Q9Y6A1; Tbio.
DR   PRO; PR:Q9Y6A1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9Y6A1; protein.
DR   Bgee; ENSG00000130714; Expressed in right hemisphere of cerebellum and 178 other cell types or tissues.
DR   ExpressionAtlas; Q9Y6A1; baseline and differential.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0031502; C:dolichyl-phosphate-mannose-protein mannosyltransferase complex; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000030; F:mannosyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc.
DR   GO; GO:0035269; P:protein O-linked mannosylation; IMP:UniProtKB.
DR   CDD; cd23281; beta-trefoil_MIR_POMT1; 1.
DR   FunFam; 2.80.10.50:FF:000012; Protein O-mannosyl-transferase 1; 1.
DR   Gene3D; 2.80.10.50; -; 1.
DR   InterPro; IPR027005; GlyclTrfase_39-like.
DR   InterPro; IPR003342; Glyco_trans_39/83.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR032421; PMT_4TMC.
DR   PANTHER; PTHR10050; DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE; 1.
DR   PANTHER; PTHR10050:SF51; PROTEIN O-MANNOSYL-TRANSFERASE 1; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF02366; PMT; 1.
DR   Pfam; PF16192; PMT_4TMC; 1.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF82109; MIR domain; 1.
DR   PROSITE; PS50919; MIR; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Congenital muscular dystrophy; Disease variant;
KW   Dystroglycanopathy; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Limb-girdle muscular dystrophy; Lissencephaly;
KW   Membrane; Metal-binding; Proteomics identification; Reference proteome;
KW   Repeat; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..747
FT                   /note="Protein O-mannosyl-transferase 1"
FT                   /id="PRO_0000121484"
FT   TRANSMEM        8..28
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        40..60
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..88
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        99..119
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        122..142
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        154..174
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        183..203
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        206..226
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        269..289
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        597..617
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        636..656
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        661..681
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          318..381
FT                   /note="MIR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          392..449
FT                   /note="MIR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          453..513
FT                   /note="MIR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   CARBOHYD        435
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        471
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        539
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..117
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041024"
FT   VAR_SEQ         1..54
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16303743"
FT                   /id="VSP_007590"
FT   VAR_SEQ         234..255
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10366449,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16303743"
FT                   /id="VSP_007591"
FT   VARIANT         65
FT                   /note="G -> R (in MDDGB1; dbSNP:rs119462983)"
FT                   /evidence="ECO:0000269|PubMed:16575835,
FT                   ECO:0000269|PubMed:16717220, ECO:0000269|PubMed:19299310"
FT                   /id="VAR_065027"
FT   VARIANT         76
FT                   /note="G -> R (in MDDGA1; dbSNP:rs28941782)"
FT                   /evidence="ECO:0000269|PubMed:12369018"
FT                   /id="VAR_015734"
FT   VARIANT         105
FT                   /note="R -> C (in MDDGA1; severe Walker-Warburg syndrome;
FT                   dbSNP:rs1289335417)"
FT                   /evidence="ECO:0000269|PubMed:16575835"
FT                   /id="VAR_065028"
FT   VARIANT         105
FT                   /note="R -> H (in MDDGA1; severe Walker-Warburg syndrome;
FT                   dbSNP:rs1554772469)"
FT                   /evidence="ECO:0000269|PubMed:16575835"
FT                   /id="VAR_065029"
FT   VARIANT         140
FT                   /note="Missing (in MDDGB1; dbSNP:rs587777820)"
FT                   /evidence="ECO:0000269|PubMed:16575835"
FT                   /id="VAR_065030"
FT   VARIANT         200
FT                   /note="A -> P (in MDDGC1; a common founder mutation;
FT                   dbSNP:rs119462982)"
FT                   /evidence="ECO:0000269|PubMed:15792865"
FT                   /id="VAR_022661"
FT   VARIANT         207
FT                   /note="G -> V (in MDDGA1; severe Walker-Warburg syndrome)"
FT                   /evidence="ECO:0000269|PubMed:16575835"
FT                   /id="VAR_065031"
FT   VARIANT         251
FT                   /note="Q -> R (in dbSNP:rs2296949)"
FT                   /evidence="ECO:0000269|PubMed:10366449,
FT                   ECO:0000269|PubMed:14702039"
FT                   /id="VAR_034390"
FT   VARIANT         251
FT                   /note="Q -> W (requires 2 nucleotide substitutions;
FT                   dbSNP:rs386738991)"
FT                   /id="VAR_034389"
FT   VARIANT         285
FT                   /note="L -> F (in dbSNP:rs201073763)"
FT                   /evidence="ECO:0000269|PubMed:16575835"
FT                   /id="VAR_065032"
FT   VARIANT         327
FT                   /note="V -> I (in dbSNP:rs4740164)"
FT                   /id="VAR_034391"
FT   VARIANT         421
FT                   /note="Missing (in MDDGA1; loss of function of alpha
FT                   dystroglycan as a matrix receptor)"
FT                   /evidence="ECO:0000269|PubMed:15037715"
FT                   /id="VAR_022662"
FT   VARIANT         428
FT                   /note="V -> D (in MDDGA1)"
FT                   /evidence="ECO:0000269|PubMed:12369018"
FT                   /id="VAR_015735"
FT   VARIANT         433
FT                   /note="D -> E (in dbSNP:rs11243406)"
FT                   /id="VAR_034392"
FT   VARIANT         522
FT                   /note="R -> K (in dbSNP:rs117985576)"
FT                   /evidence="ECO:0000269|PubMed:16575835"
FT                   /id="VAR_065033"
FT   VARIANT         537
FT                   /note="S -> R (in MDDGA1 and MDDGB1; likely benign;
FT                   dbSNP:rs150367385)"
FT                   /evidence="ECO:0000269|PubMed:15637732,
FT                   ECO:0000269|PubMed:19299310"
FT                   /id="VAR_026697"
FT   VARIANT         582
FT                   /note="W -> C (in MDDGB1; dbSNP:rs119462984)"
FT                   /evidence="ECO:0000269|PubMed:16575835"
FT                   /id="VAR_065034"
FT   VARIANT         590
FT                   /note="Q -> H (in MDDGB1; dbSNP:rs119462986)"
FT                   /evidence="ECO:0000269|PubMed:16575835,
FT                   ECO:0000269|PubMed:16717220"
FT                   /id="VAR_065035"
FT   VARIANT         669
FT                   /note="A -> T (in MDDGB1; dbSNP:rs119462987)"
FT                   /evidence="ECO:0000269|PubMed:16717220"
FT                   /id="VAR_065036"
FT   CONFLICT        37
FT                   /note="P -> Q (in Ref. 6; AAH22877)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="E -> K (in Ref. 1; AAD41245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        147
FT                   /note="I -> V (in Ref. 2; BAG58462)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        178
FT                   /note="K -> E (in Ref. 6; AAH22877)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        377
FT                   /note="I -> V (in Ref. 6; AAH22877)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        665
FT                   /note="H -> L (in Ref. 3; BAC11269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        696..697
FT                   /note="SI -> NS (in Ref. 1; AAD41245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        739
FT                   /note="S -> G (in Ref. 2; BAA91135)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   747 AA;  84881 MW;  6E1D26C87FF5D9C5 CRC64;
     MWGFLKRPVV VTADINLSLV ALTGMGLLSR LWRLTYPRAV VFDEVYYGQY ISFYMKQIFF
     LDDSGPPFGH MVLALGGYLG GFDGNFLWNR IGAEYSSNVP VWSLRLLPAL AGALSVPMAY
     QIVLELHFSH CAAMGAALLM LIENALITQS RLMLLESVLI FFNLLAVLSY LKFFNCQKHS
     PFSLSWWFWL TLTGVACSCA VGIKYMGVFT YVLVLGVAAV HAWHLLGDQT LSNVGADVQC
     CMRPACMGQM QMSQGVCVFC HLLARAVALL VIPVVLYLLF FYVHLILVFR SGPHDQIMSS
     AFQASLEGGL ARITQGQPLE VAFGSQVTLR NVFGKPVPCW LHSHQDTYPM IYENGRGSSH
     QQQVTCYPFK DVNNWWIVKD PRRHQLVVSS PPRPVRHGDM VQLVHGMTTR SLNTHDVAAP
     LSPHSQEVSC YIDYNISMPA QNLWRLEIVN RGSDTDVWKT ILSEVRFVHV NTSAVLKLSG
     AHLPDWGYRQ LEIVGEKLSR GYHGSTVWNV EEHRYGASQE QRERERELHS PAQVDVSRNL
     SFMARFSELQ WRMLALRSDD SEHKYSSSPL EWVTLDTNIA YWLHPRTSAQ IHLLGNIVIW
     VSGSLALAIY ALLSLWYLLR RRRNVHDLPQ DAWLRWVLAG ALCAGGWAVN YLPFFLMEKT
     LFLYHYLPAL TFQILLLPVV LQHISDHLCR SQLQRSIFSA LVVAWYSSAC HVSNTLRPLT
     YGDKSLSPHE LKALRWKDSW DILIRKH
//
